Breaking News
September 26, 2018 - New insights into what drives organ transplant rejection
September 26, 2018 - Tiny Device Is a ‘Huge Advance’ for Treatment of Severe Heart Failure
September 26, 2018 - Research shows possibility to postpone cumbersome treatment for low-risk MDS patients
September 26, 2018 - CSU chemists may help in making extracorporeal life support devices more effective
September 26, 2018 - Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer’s disease
September 26, 2018 - PCORI, AHRQ announce awards to support patient-centered outcomes research in learning health systems
September 26, 2018 - Scientists discover and characterize human skeletal stem cells
September 26, 2018 - Repeat CT Common in Peds Traumatic Epidural Hematoma
September 26, 2018 - Genetics Home Reference: bunion
September 26, 2018 - Increase observed in hearts from drug-intoxicated donors
September 26, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 26, 2018 - TINY cancer detection device shows promise as point-of-care detector of KSHV
September 26, 2018 - Women with non-small cell lung cancers live longer than their male counterparts
September 26, 2018 - KTU researchers engineer experimental bone to help treat osteoarthritis patients
September 26, 2018 - Foundation for a Smoke-Free World calls for proposals to implement Smoke-Free Index
September 26, 2018 - Functional Imagery Training helps lose five times more weight than talking therapy
September 26, 2018 - Fewer American Teens Having Sex, Most Using Birth Control
September 26, 2018 - We are predisposed to forgive, new research suggests
September 26, 2018 - Insomnia Exacts Heavy Toll on Quality of Life
September 26, 2018 - Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility
September 26, 2018 - Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s
September 26, 2018 - Study finds persistent rate of lawnmower injury-related emergency department visits
September 26, 2018 - Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson’s disease
September 26, 2018 - Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award
September 26, 2018 - New spinout company to tackle drug-resistant infections with novel antibiotics
September 26, 2018 - In depression the brain region for stress control is larger
September 26, 2018 - Smuggling RNA into cells can activate the immune system to fight cancer
September 26, 2018 - Special Focus Issue takes wide view of complementary and integrative medicine in cancer
September 26, 2018 - Researchers now confirm that genome duplication drives evolution of species
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Patients with paralysis manage to walk thanks to new technology
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - New model enables anyone to run powerful simulations, complex calculations easily
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
Hunting for immune cells’ cancer targets

Hunting for immune cells’ cancer targets

image_pdfDownload PDFimage_print
Proteins on immune cells called T-cell receptors (red) detect specific protein snippets (yellow) on the surface of other cells, including tumor cells. A new technique lets researchers find snippets linked to cancer. Credit: Eric Smith and Christopher Garcia

By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer.

The screening technology, developed by Howard Hughes Medical Institute Investigator (HHMI) Christopher Garcia and colleagues after almost 20 years of basic molecular studies of the immune system, may ultimately lead to more effective immunotherapies, which harness the body’s immune system to fight cancer. “This is going to widen the scope of our understanding for how tumors are recognized,” says Garcia, a protein engineer at the Stanford University School of Medicine.

More broadly, the method, reported online December 21, 2017, in the journal Cell, promises to illuminate how immune cells lock onto targets, the cellular recognition at the heart of autoimmune disorders and infections. Without a systematic way to look for these signals, many details of immune cells’ recognition capabilities have remained a mystery.

One type of immune cell, called a tumor-infiltrating lymphocyte, can invade tumors and help destroy cancer cells. Tumor-infiltrating lymphocytes have captured the attention of cancer researchers eager to supercharge these cells’ tumor-killing abilities. This destruction depends on lymphocytes correctly detecting cancer signals – bits of protein called antigens that cancer cells display on their surface. Lymphocytes use proteins called T-cell receptors to lock on to these cancer signals, many of which are unknown.

In 2014, Garcia and colleagues published an article in Cell reporting a discovery that T-cell receptors were far more specific for their targets than originally thought. They were able to make this discovery by developing a biochemical method to sift through millions of antigens that might be detected by T-cell receptors. In the new work, they apply a similar method to tumor samples from two colorectal cancer patients, this time searching for the actual targets of patients’ tumor-invading lymphocytes.

Along with graduate student Marvin Gee, Garcia enlisted the collaboration of Mark Davis, an HHMI investigator at Stanford University. Davis’s laboratory has developed ways to read the DNA sequences of single lymphocytes – information that helped researchers hunt for immune cells’ targets. First, Davis and post-doctoral fellow Arnold Han isolated and characterized T-cell receptors from two patients with colorectal cancer. Next, the researchers used those precise T-cell receptors as bait, a labor-intensive process that involves searching through hundreds of millions of signals that cancer cells might display. These signals, short strings of amino acids, represent molecular needles in an enormous haystack.

But the method worked. And the researchers discovered something surprising: Out of a huge number of possibilities, the T-cell receptors from both patients recognized the same tumor antigen. The results support the approach of developing broadly effective cancer treatments based on the immune system. “We have to find antigens that are shared across multiple different patients, so that one treatment can serve many different people,” Garcia says.

These shared signals could prove useful in several ways. In laboratories, researchers could genetically engineer T-cell receptors to recognize common cancer antigens. Once introduced into a patient’s body, these cells would make a beeline to the tumor cells. A related approach would turn the cancer antigen itself into a vaccine. After an injection, this cancer vaccine would teach existing immune cells to recognize and combat the rogue cells.

The new results have implications that reach far beyond cancer, too. The method could illuminate the cellular details of autoimmune disorders, infectious diseases or any other process that involves T-cell receptors, Garcia says.

The current findings were rooted in a result from 1996, when Garcia and colleagues first solved the 3-D structure of a T-cell receptor bound to a target. Since then, the work has moved steadily from basic research to clinically relevant insights, Garcia says. “This is a great example of how starting with the most reductionist approach can lead you to very powerful insights with clinical relevance,” he says. “If you invest in the most basic discovery science, and you go deep enough on an important problem, here’s what can come out the other end.”


Explore further:
Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

More information:
Cell (2017). DOI: 10.1016/j.cell.2017.11.043

Journal reference:
Cell

Provided by:
Howard Hughes Medical Institute

Tagged with:

About author

Related Articles